Effective half life of iodine for five thyroidectomy patients using an in vivo gamma camera approach

Journal of Radiation Research

Volumn 48, Issue 6, 2007, Pages 485-493

  Chen, Chien Yi ^a   Chang, Pai Jung ^b   Changlai, Sheng Pin ^b   Pan, Lung Kwang ^c  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Ablation; Biological half life; Effective half life; Iodine; Thyroid; Thyroidectomy

Indexed keywords

BODY FLUIDS; CAMERAS; IODINE; MATLAB;

BIOLOGICAL HALF LIFE; BODY COMPARTMENTS; EFFECTIVE HALF-LIVES; GAMMA-CAMERA; HALF LIVES; IN-VIVO; RADIOACTIVE IODINE; THYROID; THYROIDECTOMY; WHOLE-BODY;

ABLATION;

ERAGROSTIS TEF;

EID: 36749045163     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1269/jrr.07031     Document Type: Article

References (21)

1. De klerk, J. M. H., Keizer, B. De., Zelissen, P. M. J., Lips, C. M. J. and Koppeschaar, H. P. F. (2000) Fixed dosage of I-131 for remnant ablation in patients with differentiated thyroid carcinoma without pre-ablative diagnostic I-131 scintigraphy. Nuclear Medicine Communications, 21: 529-532.
2. Schlumberger, M. J. (1998) Rapillary and follicular thyroid carcinoma. New England J. Medicine, 338: 297-306.
3. Young, R. L., Mazzaferri, E. L., Rahe, A. J. and Dorfman, S. G. (1980) Pure follicular thyroid carcinoma: impact of therapy in 214 patients. J Nucl Med, 21: 733-737.
4. Maxon, H. R. and Smith, H. S. (1990) Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer. Endocrinol Metab Clin North Am, 19: 685-719.
5. Kramer, G. H., Hauck, B. M. and Chamerland, M. J. (2002) Biological half-life of iodine in adults with intact thyroid function and in athyreoticpersons. Radiation Protection Dosimetry, 102(2): 129-135.
6. North, D. L., Shearer, D. R., Hennessey, I. V. and Donovan, G. L. (2001) Effctive half-life of I-131 in thyroid cancer patients. Health Physics, 81(3): 325-329.
7. Erdi, Y. E., Macapinlach, H., Larson, S. M., Erdi, A. K., Yeung, H., Furhang, E. E. and Humm, J. L. (1999) Radiation dose assessment for I-131 therapy of thyroid cancer using I-124 pet imaging. Clinical Positron Imaging, 2(1): 41-46.
8. ICRP (1978) Limits for intakes of radionuclides by workers. Technical Report ICRP-30, International commission on radiation protection, Pergamon Press, Oxford.
9. Takamura, N., Nakmura, Y., Ishigaki, K., Ishigaki, J., Mine, M., Aoyagi, K. and Yamashita, S. (2004) Thyroid blockade during a radiation emergency in iodine-rich area: effect of a stableiodine dosage. Journal Radiation Research, 45(2): 201-204.
10. Nitta, Y., Endo, S., Fujimoto, N., Kamiya, K. and Hoshi, M. (2001) Age-dependent exposure to radioactive iodine I-131 in the thyroid and total body of newborn, pubertal and adult fischer 344 rats. Journal Radiation Research, 42(2): 143-155.
11. Adams, N. and Fell, T. P. (1988) Recycling and metabolic models for internal dosimetry: with special reference to iodine. Radiation Protection Dosimetry, 22(3): 179-182.
12. Chen, C. Y., Chang, P. J., Pan, L. K., ChangLai, S. P. and Chan, C. C. (2003) Effective half life of I-131 of whole body and individual organs for thyroidectomy patient using scintigraphic images of gamma-camera. Chung Shan Medical J, ROC, 14: 557-565.
13. Pan, L. K. and Tsao, C. S. (2000) Verification of the neutron flux of a modifed zero-power reactor using a neutron activation method. Nucl. Sci. and Eng., 135: 64-72.
14. Pan, L. K. and Chen, C. Y. (2001) Trace elements of taiwanese dioscorea spp. using instrumental neutron activation analysis. Food Chemistry, 72: 255-260.
15. Loevinger, R., Budinger, T. F. and Watson, E. E. (1991) Mird Primer for absorbed Dose Calculations, Society of Nuclear Medicine. Incorp. revisded ed., Amazon.
16. NRC1997b (1997) Release of patients administered radioactive materials. Technical Report Regulatory Guide 8. 39, U.S. Nuclear Regulatory Commission.
17. Mathieu, I., Gaussin, J., Smeesters, P., Wambersie, A. and Beckers, C. (1999) Recommended restrictions after I-131 therapy: measured doses in family members. Health Physics, 76(2): 129-136.
18. Snyder, J., Gorman, C. and Scanlon, P. (1983) Thyroid remnants ablation: Questionable pursuit of all-defined goals. J. Nuclear Medicine, 24(8): 659-665.
19. Berg, G. E. B., Annika, M. K., Erik, C. V., Holmberg and Margareta Fink (1996) Iodine-131 treatment of hyperthyroidism: significance of effective half life measurements. J. Nuclear Medicine, 37(2): 228-232.
20. Zanzonico, P. (2000) Age-dependent thyroid absorbed doses for radiobiologically significant radioisotopes of iodine. Health Physics, 78: 60V67.
21. Desantis, D. M. and Chabot, G. E. (2001) An alternative method for the release criteria and calculation of the total dose equivalent to another individual from a patient treated with a therapeutic dose of I-131. Health Physics, 81(1): 15-26.